Biopixels
Fluicell's issuance will accelerate development of diabetes treatment
Fluicell develops tissue-based products with the goal of offering treatment alternatives for serious and incurable diseases such as type 1 diabetes, cardiovascular diseases and...
Fluicell CEO: “Type 1 diabetes is just the beginning of our growth journey”
Fluicell has developed a tissue platform based on high-resolution...
Fluicell signs agreement with big pharma for 3-D bioprinting project
Fluicell, which develops single-cell technology, has a good reputation...
2021 marks the beginning of a new era for Fluicell
With summer around the corner, BioStock takes a closer look at...
Fluicell invests in regenerative medicine
Regenerative medicine is an emerging field of research that focuses...
The sales team – a key component in Fluicell's growth
For a company like Fluicell, which focuses on...
Fluicell launches Biozone 6
In the field of single cell technology for research and development,...
2020 – a year of growth and expansion for Fluicell
Fluicell started 2020 by implementing the first...
Fluicell leverages microfluidics to become a leader in biomedicine
Even though Fluicell is a small company,...
Fluicell makes its mark in neuroscience
Neurodegenerative diseases are a rapidly growing problem with...
Fluicell raises SEK 4 million in private placement
In mid-October, Fluicell announced that it...
Fluicell will meet the need for new experimental models
Animal models are an essential part of research and...
Notes
AstraZeneca's baxdrostat meets all Phase III targets
NOSA receives positive results from in vivo study
Iconovo reports Q2
NextCell recognized in FUJIFILM's strategic vision
Mentice consolidates operations to Denver
NEWSLETTER
NEWS
Rights issue strengthens AlzeCure's position
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
